Historical perspective

Childhood Leukemias, Second Edition

Volumn , Issue , 2006, Pages 3-20

  Pinkel, Donald ^a  

^a CALIFORNIA POLYTECHNIC STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84932613954     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511471001.002     Document Type: Chapter

References (207)

1. Aur, R. J. A., Simone, J. V., Hustu, H. O., et al. Central nervous system therapy and combination chemotherapy of childhood lymphocytic leukemia. Blood, 1971; 37: 272-81.
2. Velpeau, A. Sur la resorption du pusaet sur l'alteration du sang dans les maladies clinique de persection nenemant. Premier observation. Rev Med, 1827; 2: 216.
3. Virchow, R. Weisses blut. Notiz Geb Natur Heilk, 1845; 36: 152-6.
4. Bennett, J. H. Case of hypertrophy of the spleen and liver in which death took place from suppuration of the blood. Edinburgh Med Surg J, 1845; 64: 413-23.
5. Craigie, D. Case of disease of the spleen in which death took place in consequence of the presence of purulent matter in the blood. Edinburgh Med Surg J, 1845; 64: 400-13.
6. Virchow, R. Die leukämie. In R. Virchow, ed., Gesammelte abhandlungen zur wissenschaft lichen medizin (Frankfurt, Germany: Meidinger, 1856), pp. 190-211.
7. Friedreich, N. Ein neuer fall von leukämie. Virchow's Arch Pathol Anat, 1857; 12: 37-58.
8. Neumann, E. Ueber myelogene leukämie. Berl Klin Wochenschr, 1878; 15: 69-72.
9. Turk, W. Ein system der lymphomatosen. Wien Klin Wochenschr, 1903; 16: 1073-85.
10. Ehrlich, P. Farbenanalytische untersuchungen zur histologie und klinick des blutes (Berlin: Hirschwald, 1891).
11. Reschad, H. & Schilling-Torgau, V. Ueber eine neue leukämie durch echte uebergangsformen und ihre bedeutung fur dies selbständigkeit dieser zellen. Munch Med Wochenschr, 1913; 60: 1981-4.
12. Ward, G. The infective theory of acute leukemia. Br J Child Dis, 1917; 14: 10-20.
13. Bennett, J. M., Catovsky, D., Daniel, M.-T., et al. Criteria for the diagnosis of acute leukemia of megakaryocytic lineage (M7). A report of the French-American-British Cooperative Group. Ann Intern Med, 1985; 103: 460-2.
14. Nowell, P. C. & Hungerford, D. A. A minute chromosome in human chronic granulocytic leukemia. Science, 1960; 132: 1497.
15. Rowley, J. D. A new consistent chromosome abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature, 1973; 243: 290-3.
16. Jurlander, J., Caliguri, M. A., Ruutu, T., et al. Persistence of AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood, 1996; 88: 2183-91.
17. Guthrie, R. Organization of a regional newborn screening laboratory. Neonatal Screening for Inborn Errors of Metabolism (Berlin: Springer, 1980), In H. Bickel, R. Guthrie & G. Hammersen, eds., pp. 259-70.
18. Ford, A.M., Ridge, S. A., Cabrera, M.E., et al. In utero rearrangements in the trithorax-related oncogene in infant leukaemias. Nature, 1993; 363: 358-60.
19. Gale, K. B., Ford, A. M., Repp, R., et al. Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A, 1997; 94: 13 950-4.
20. Wiemels, J. L., Cazzaniga, G., Daniotti, M., et al. Prenatal origin of acute lymphoblastic leukaemia in children. Lancet, 1999; 354: 1499-1503.
21. Yagi, T., Hibi, S., Tabata, Y., et al. Detection of clono typic IGH and TCR rearrangements in the neonatal blood spots of infants and children with B-cell precursor acute lymphoblastic leukemia. Blood, 2000; 96: 264-8.
22. Taub, J. W., Konrad, M. A., Ge, Y., et al. High frequency of leukemic clones in newborn screening blood samples of children with B-precursor acute lymphoblastic leukemia. Blood, 2002; 99: 2992-6.
23. Wiemels, J. L., Xiao, Z., Buffler, P. A., et al. In utero origin of t(8;21) AML1-ETO translocations in childhood acute myeloid leukemia. Blood, 2002; 99: 3801-5.
24. Greaves, M. Childhood leukaemia. BMJ, 2002; 324: 283-7.
25. Borella, L. & Sen, L. T cell surface markers on lymphoblasts from acute lymphocytic leukemia. J Immunol, 1973;111: 1257-60.
26. Sen, L. & Borella, L. Clinical importance of lymphoblasts with T markers in childhood acute leukemia. N Engl J Med, 1975; 92: 828-32.
27. Ritz, J., Pesando, J. M., Notis-McConarty, J., et al. A monoclonal antibody to human acute lymphoblastic leukemia antigen. Nature, 1980; 283: 583-5.
28. Pui, C. H. & Crist, W. M. Biology and treatment of acute lymphoblastic leukemia. J Pediatr, 1994; 124: 491-503.
29. Romana, S. P., Poirel, H., Leconiat, M., et al. High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia. Blood, 1995; 86: 4263-9.
30. Pinkel, D. Genotypic classification of childhood acute lymphoid leukemia. Leukemia, 1999; 13(Suppl.): S90-1.
31. Jaffe, E. S., Harris, N. L., Stein, H., & Vardiman, J.W., eds. World Health Organization Classification of Tumors. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues (Lyon, France: IARC Press, 2001).
32. Vardiman, J. W., Harris, N. L., & Brunning, R. D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood, 2002; 100: 2292-302.
33. Walters, T. R., Bushore, M., & Simone, J. Poor prognosis in Negro children with acute lymphocytic leukemia. Cancer, 1972; 29: 210-14.
34. Viana, M. B., Murao, M., Ramos, G., et al. Malnutrition as a prognostic factor in lymphoblastic leukemia: a multivariate analysis. Arch Dis Child, 1994; 71: 304-10.
35. Lobato-Mendizabal, E., Ruiz-Arguelles, G. J., & Marin-Lopez, A. Leukemia and nutrition: malnutrition is an adverse prognostic factor in the outcome of treatment of patients with standard risk acute lymphoblastic leukemia. Leuk Res, 1989; 13: 899-906.
36. Lobato-Mendizabal, E., Ruiz-Arguelles, G. J., & Ganci-Cerrud, G. Effects of socioeconomic statusonthe therapeutic response of children with acute lymphoblastic leukemia of common risk. Neoplasia, 1991; 8: 161-5.
37. Hord, M. H., Smith, T. L., Culbert, S. J., et al. Ethnicity and cure rates of Texas children with acute lymphoid leukemia. Cancer, 1996; 77: 563-9.
38. Krivit, W.&Good, R. A. Simultaneous occurrence of mongolism and leukemia. AMA J Dis Child, 1957; 94: 289-93.
39. Ravindrinath, Y., Abella, E., Krischer, J. P., et al. Acute myeloid leukemia in Down's syndrome is highly responsive to chemotherapy: experience of Pediatric Oncology Group AML Study 8498. Blood, 1992; 80: 2210-4.
40. Douer, D., Preston-Martin, S., Chang, E. et al. High frequency of acute promyelocytic leukemia among Latinos with acute myeloid leukemia. Blood, 1996; 87: 308-13.
41. Lennard, L., Lilleyman, J. S., Van Loon, J., et al. Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet, 1990; 336: 225-9.
42. McLeod, H. L., Relling, M. V., Liu, Q., et al. Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia. Blood, 1995; 85: 1897-1902.
43. Wiemels, J. L., Pagnamenta, A., Taylor, G. M., et al. A lack of a functional NAD(P)H: quinone oxidoreductase allele is selectively associated with pediatric leukemias that have MLL fusions. United Kingdom Childhood Cancer Study Investigators. Cancer Res, 1999; 59: 4095-9.
44. Wiemels, J. L., Smith, R. N., Taylor, G. M., et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci U S A, 2001; 98: 4004-9.
45. Ellerman, V.&Bang, O. Experimentelle leukämie bei hühnern. Zentrabl Bakteriol, 1908; 46: 595-609.
46. Gross, L. "Spontaneous" leukemia developing in C3Hmice following inoculation, in infancy, with AK-leukemic extracts or AK-embryos. Proc Soc Exp Biol Med, 1951; 76: 27-32.
47. Rickard, C. G., Post, J. E., Noronha, F., et al. A transmissable virus-induced lymphocytic leukemia of the cat. J Natl Cancer Inst, 1969; 42: 987-1014.
48. Miller, J. M., Miller, L. D., Olson, C. & Gillette, K. G. Virus-like particles in phytohemagglutinin-stimulated lymphocyte cultures with reference to bovine lymphosarcoma. J Natl Cancer Inst, 1969; 43: 1297-1305.
49. Kawakami, T. G., Huff, S. D., Buckley, P. M., et al. C-type virus associated with gibbon lymphosarcoma. Nat New Biol, 1972; 235: 170-1.
50. Poiesz, B. J., Ruscette, F. W., Gagdar, A. F., et al. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci U S A, 1980; 77: 7415-19.
51. Churchill, A. E. & Biggs, P. M. Agent of Marek disease in tissue culture. Nature, 1967; 215: 528-30.
52. Epstein, M. A., Achong, B. G., & Barr, Y. M. Virus particles in cultured lymphoblasts from Burkitt'slymphoma. Lancet, 1964; 15: 702-3.
53. Pagano, J. S. Epstein-Barr virus: the first human tumor virus and its role in cancer. Proc Assoc Am Physicians, 1999; 111: 573-80.
54. Smith, J. W., Freeman, A. & Pinkel, D. Search for a human leukemia virus. Archiv Gesamte Virusforschung, 1967; 22: 294-302.
55. Cooke, J. V. The incidence of acute leukemia in children. JAMA, 1942; 119: 547-50.
56. Kellett, C. E. Acute myeloid leukemia in one of identical twins. Arch Dis Child, 1937; 12: 239-52.
57. Pinkel, D. & Nefzger, D. Some epidemiological features of childhood leukemia in the Buffalo, NY, area. Cancer, 1959; 12: 351-8.
58. Pinkel, D., Dowd, J. E. & Bross, I. D. J. Some epidemiological features of malignant solid tumors of children in the Buffalo, NY, area. Cancer, 1963; 16: 28-33.
59. Heath, C. W. & Hasterlik, R. J. Leukemia among children in a suburban community. Am J Med, 1963; 34: 796-812.
60. Knox, G. Epidemiology of childhood leukemia in Northumberland and Durham. Br J Prev Soc Med, 1964; 18: 17-24.
61. Lock, S. P. & Merrington, M. Leukemia in Lewisham (1957-1963). Br Med J, 1967; 3: 759-60.
62. Ederer, F., Myers, M. H., Eisenberg, H., et al. Temporal-spatial distribution of leukemia and lymphoma in Connecticut. J Natl Cancer Inst, 1965; 35: 625-9.
63. Kinlen, L. J., Dickson, M., & Stiller, C. A. Childhood leukemia and non-Hodgkin's lymphoma near large rural construction sites, with acomparison with Sellafield nuclear site. BMJ, 1995; 310: 763-8.
64. Greaves, M. F.& Alexander, F. E. An infectious etiology for common acute lymphoblastic leukemia in childhood? Leukemia, 1993; 7: 349-60.
65. Greaves, M.F., Colman, S. M., Beard, M.E. J., et al. Geographical distribution of acute lymphoblastic leukemia subtypes: second report of the collaborative group study. Leukemia, 1993; 7: 27-34.
66. March, H. C. Leukemia in radiologists. Radiology, 1944; 43: 275-8.
67. Folley, J. H., Borges, W., & Yamawaki, T. Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. Am J Med, 1952; 13: 311-21.
68. Simpson, C. L., Hempelman, L. H., & Fuller, L. M. Neoplasia in children treated with x-rays in infancy for thymic enlargement. Radiology, 1955; 64: 840-5.
69. Stewart, A., Webb, J., Gates, D., et al. Malignant disease in childhood and diagnostic irradiation in utero. Lancet, 1956; 2: 447.
70. Ron, E., Modan, B., & Boice, J. D., Jr. Mortality after radiotherapy for ring worm of the scalp. Am J Epidemiol, 1988; 127: 713-25.
71. Kadhim, M. A. & Wright, E. G. Radiation-induced transmissable chromosomal instability in haemopoietic stem cells. Adv Space Res, 1998; 22: 587-96.
72. Delore, P. & Borgomano, C. Leucémie aigue au cours de l'intoxication benzenique: sur l'origine toxique de certaines leucémies aigues et leurs relations avec les anémies graves. J Méd Lyon, 1928; 9: 227-33.
73. Aksoy, M., Erdem, S., & Dincol, G. Leukemia in shoe workers exposed chronically to benzene. Blood, 1974; 44: 837-41.
74. Vigliani, E. C. & Saita, G. Benzene and leukemia. N Engl J Med, 1964; 271: 872-6.
75. Hayes, R. B., Yin, S. N., Dosemeci, M., et al. Mortality among benzene-exposed workers in China. Environ Health Perspect, 1996; 104 (Suppl. 6): 1349-52.
76. Hoffmann, D., Brunnemann, K. D., & Hoffman, I. Significance of benzene in tobacco carcinogenesis. In M. A. Mehlman, ed., Benzene: Occupational and Environmental Hazards: Scientific Update (Princeton, NJ: Princeton Scientific Publications, 1989), pp. 99-112.
77. Smith, M. T. The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ Health Perspect, 1996; 104(Suppl. 6): 1219-25.
78. Thompson, J. R., Gerald, P. F., Willoughby, L. N., et al. Maternal folate supplementation in pregnancy and protection against acute lymphoblastic leukaemia in childhood: a case-control study. Lancet, 2001; 358: 1935-40.
79. Tucker, M. A., Meadows, A. T., Boice, J. D., et al. Leukemia after therapy with alkylating agents for childhood cancer. J Natl Cancer Inst, 1987; 78: 459-64.
80. Pui, C.-H., Behm, F. G., Raimondi, S. C., et al. Secondary acutemyeloid leukemia in children treated for acute lymphoid leukemia. N Engl J Med, 1989; 321: 136-42.
81. Alexander, F. E., Patheal, S. L., Biondi, A., et al. Transplacental chemical exposure and risk of infant leukemia with MLL gene fusion. Cancer Res, 2001; 61: 2542-6.
82. Hartenstein, Ber Veterinärw, Sachsen: 1876; 44: 41: As cited by Engelbreth-Holm, J. In Spontaneous and Experimental Leukemia in Animals (Edinburgh, UK: Oliver and Boyd, 1942), p. 130.
83. Slye, M. The relation of heredity to the occurence of spontaneous leukemia, pseudoleukemia, lymphosarcoma and allied diseases in mice. Preliminary report. Am J Cancer, 1931; 15: 1361-86.
84. MacDowell, E. C. & Richter, M. N. Mouse leukemia. IX. The role of heredity in spontaneous cases. Arch Pathol, 1935; 20: 709-24.
85. Ardashnikov, S. N. The genetics of leukemia in man. J Hyg, 1937; 37: 286-302.
86. Videbaek, A. Heredity in Human Leukemia and its Relation to Cancer: A Genetic and Clinical Study of 209 Probands (London: HKLewis, 1947).
87. Steinberg, A. G. A genetic and statistical study of acute leukemia in children. InProceedings of the Third National Cancer Conference (Philadelphia, PA: J. B. Lippincott, 1957), pp. 353-6.
88. Siegel, A. E. Lymphocytic leukemia occurring in twins. Atlantic Med Monthly J, 1928; 31: 748-9.
89. MacMahon, B. & Levy, M. A. Prenatal origin of childhood leukemia. Evidence from twins. N Engl J Med, 1964; 270: 1082-5.
90. Brewster, H. F. & Cannon, H. E. Acute lymphatic leukemia: report of a case in an eleventh month mongolian idiot. New Orleans Med Surg J, 1930; 82: 872-3.
91. Miller, R. W. Persons with an exceptionally high risk of leukemia. Cancer Res, 1967; 27: 2420-3.
92. De Klein, A., Kessel, A. G. van, Grosveld, G., et al. A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukemia. Nature, 1982; 300: 765-7.
93. Dalla-Favera, R., Bregni, M., Erikson, J., et al. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A, 1982; 79: 7824-7.
94. Pinkel, D. Curing children of leukemia. Cancer, 1987; 59: 1683-91.
95. Deininger, M. W., Goldman, J. M., & Melo, J. V. The molecular biology of chronic myeloid leukemia. Blood, 2000; 96: 3343-56.
96. Blackwood, E. M. & Eisenman, R. N. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science, 1991; 251: 1211-17.
97. Lissauer, H. Zwei fälle von leucaemie. Berl Klin Wochenschr, 1865; 2: 403-4.
98. Senn, N. The therapeutical value of the Roentgen ray in the treatment of pseudoleukemia. NYMed J, 1903; 77: 665-8.
99. Lawrence, J. H. Nuclear physics and therapy: preliminary report on a new method for the treatment of leukemia and polycythemia. Radiology, 1940; 35: 51-60.
100. Krumbhaar, E. B. & Krumbhaar, H. D. The blood and bone marrow in yellow cross (mustard gas) poisoning. Changes produced in the bone marrow of fatal cases. J Med Res, 1919; 40: 497-506.
101. Alexander, A. F. Medical report of the Bari harbor mustard casualties. Mil Surg, 1947; 101: 1-17.
102. Goodman, L. S., Wintrobe, M.W., Dameshek, W., et al. Nitrogen mustard therapy. Use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia, and certain allied and miscellaneous disorders. JAMA, 1946; 132: 126-132.
103. Karnofsky, D. A. Summary of results obtained with nitrogen mustard in the treatment of neoplastic disease. Ann NY Acad Sci, 1958; 68: 889-914.
104. Mitchell, H. K., Snell, E. E., &Williams, R. J. The concentration of "folic acid". J Am Chem Soc, 1941; 63: 2284.
105. Angier, R. B., Boothe, J. H., Hutchings, B. L., et al. The structure and synthesis of the liver (L. casei) factor. Science, 1946; 103: 667-9.
106. Spies, T. D. Treatment of macrocytic anemia with folic acid. Lancet, 1946; 1: 225-8.
107. Farber, S., Diamond, L. K., Mercer, R. D., et al. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-amino-pteroylglutamic acid (aminopterin). NEngl J Med, 1948; 238: 787-93.
108. Farber, S., Toch, R., Sears, E. M., et al. Advances in chemotherapy of cancer in man. Adv Cancer Res, 1956; 4: 1-71.
109. Seeger, D. R., Smith, J. M., & Hultquist, M. E. Antagonist for pteroylglutamic acid. J Am Chem Soc, 1947; 69: 2567.
110. Farber, S. The effect of ACTH in acute leukemia in childhood. In J. R. Mote, ed., First Clinical ACTH Conference (New York: Blakiston, 1950).
111. Elion, G. B., Hitchings, G. H., & Vanderwerff, H. Antagonists of nucleic acid derivatives. VI. Purines. J Biol Chem, 1951; 192: 505-18.
112. Burchenal, J. H., Murphy, M. L., Ellison, R. R., et al. Clinical evaluation of a new antimetabolite, 6-mercaptopurine, in treatment of leukemia and allied diseases. Blood, 1953; 8: 965-99.
113. Fernbach, D. J., Sutow, W. W., Thurman, W. G., et al. Clinical evaluation of cyclophosphamide. A new agent for the treatment of children with acute leukemia. JAMA, 1962; 182: 30-7.
114. Karon, M. R., Freireich, E. J., & Frei, E., III. A preliminary report on vincristine sulfate: a new active agent for the treatment of acute leukemia. Pediatrics, 1962; 30: 791-6.
115. Gloor, W. Ein fall von geheiltermyeloblastenleukämie. Munch Med Wochenschr, 1930; 77: 1096-8.
116. Burchenal, J. H. &Murphy, M. L. Long-termsurvivors in acute leukemia. Cancer Res, 1965; 25: 1491-4.
117. Zuelzer, W.W. Implications of long-termsurvival in acute stem cell leukemia of childhood treated with composite cyclic therapy. Blood, 1964; 24: 477-94.
118. Krivit, W., Gilchrist, G., & Beatty, E. The need for chemotherapy after prolonged complete remission in acute leukemia of childhood. J Pediatr, 1970; 76: 138-41.
119. Skipper, H. E., Schabel, F. M., Bell, M., et al. On the curability of experimental neoplasms. I. A-methopterin and mouse leukemias. Cancer Res, 1957; 17: 717-26.
120. Goldin, A., Venditti, J. M., Humphreys, S. R., et al. Influence of the concentration of leukemic inoculum on the effectiveness of treatment. Science, 1956; 123: 840.
121. Frei, E., III, Holland, J. F., Schneiderman, M. A., et al. A comparative study of two regimens of combination chemotherapy in acute leukemia. Blood, 1958; 13: 1126-48.
122. Frei, E., III, Freireich, E. J., Gehan, E., et al. Studies of sequential and combination antimetabolite therapy in acute leukemia. 6-mercaptopurine and methotrexate. Blood, 1961; 18: 431-54.
123. Frei, E., III, Karon, M., Levin, R. H., et al. The effectiveness of combinations of antileukemia agents in inducing and maintaining remission in children with acute leukemia. Blood, 1965; 26: 642-56.
124. Henderson, E. S. Combination chemotherapy of acute lymphocytic leukemia of childhood. Cancer Res, 1967; 27: 2570-2.
125. Henderson, E. S. & Samaha, R. J. Evidence that drugs in multiple combinations have materially advanced the treatment of human malignancies. Cancer Res, 1969; 29: 2272-80.
126. George, P., Hernandez, K., Hustu, O., et al. A study of "total therapy" of acute leukemia in children. J Pediatr, 1968; 72: 399-408.
127. Pinkel, D. Five-year follow-up of "total therapy" of childhood lymphocytic leukemia. JAMA, 1971; 216: 648-52.
128. Simone, J. V. Treatment of children with acute lymphocytic leukemia. Adv Pediatr, 1972; 19: 13-45.
129. Pinkel, D., Hernandez, K., Borella, L., et al. Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer, 1971; 27: 247-56.
130. Aur, R. J. A., Simone, J. V., Hustu, H. O., et al. A comparative study of central nervous system irradiation and intensive chemotherapy early in remission of childhood acute lymphocytic leukemia. Cancer, 1972; 29: 381-91.
131. Jacquillat, C., Weil, M., Gemon, M.-F., et al. Combination therapy in 130 patients with acute lymphoblastic leukemia (Protocol O6 LA 66-Paris). Cancer Res, 1973; 33: 3278-84.
132. Sullivan, M. P., Chen, T., Dyment, P. G., et al. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute lymphatic leukemia. A Pediatric Oncology Group study. Blood, 1982; 60: 948-58.
133. Rivera, G. K., Pinkel, D., Simone, J. V., et al. Treatment of acute lymphoblastic leukemia: 30 years experience at St. Jude Children's Research Hospital. N Engl J Med, 1993; 329: 1289-95.
134. Miller, R. W. & McKay, F. W. Decline in US childhood cancer mortality, 1950 through 1980. JAMA, 1984; 251: 1567-70.
135. Birch, J. M., Marsden, H. B., Morris Jones, P. H., et al. Improvements in survival from childhood cancer: results of a population based survey over 30 years. BMJ, 1988; 296: 1372-6.
136. Ellison, R. R, Holland, J. F., Weil, M., et al. Arabinosyl cytosine, a useful agent in the treatment of leukemia in adults. Blood, 1968; 32: 507-23.
137. Howard, J. P., Albo, V., Newton, W. A. Cytosine arabinoside. Results of a cooperative study in acute childhood leukemia. Cancer, 1968; 21: 341-5.
138. Holton, C. P., Lonsdale, D., Nora, A. H., et al. Clinical study of daunomycin in children with acute leukemia. Cancer, 1968; 22: 1014-17.
139. Hill, J. M., Roberts, J., Loeb, E., et al. L-asparaginase therapy for leukemia and other malignant neoplasms. JAMA, 1967;202: 882-8.
140. Mathé, G., Schwarzenberg, L., Pouillart, P., et al. Two epipodophyllotoxin derivatives, VM 26 and VP 16213, in the treatment of leukemias, hematosarcomas and lymphomas. Cancer, 1974; 34: 985-92.
141. Djerassi, I., Farber, S., Abir, E., et al. Continuous infusion of methotrexate in children with acute leukemia. Cancer, 1967; 20: 233-42.
142. Lauer, S. J., Pinkel, D., Buchanan, G. R., et al. Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Cancer, 1987; 60: 2366-71.
143. Patte, C., Thierry, P., Chantal, R., et al. High survival rate in advanced-staged B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy. J Clin Oncol, 1991; 9: 123-32.
144. Gee, T. S., Yu, K.-P., & Clarkson, B. D. Treatment of adult acute leukemia with arabinosylcytosine and thioguanine. Cancer, 1969; 23: 1019-32.
145. Dahl, G. V., Kalwinsky, D. K., Mirro, J. et al. A comparison of cytokinetically based versus intensivechemo therapy for childhood acute myelogenous leukemia. Hematol Blood Transfusion, 1987; 30: 83-7.
146. Perel, Y., Aurvrignon, A., Leblanc, T., et al. Impact of addition of maintenance therapy to intensive induction and consolidation chemotherapy for childhood acute myeloblastic leukemia: results of a prospective randomized trial, LAME 89/91. J Clin Oncol, 2002; 20: 2774-82.
147. Woods, W. G., Neudorf, S., Gold, S., et al. A comparison of allogeneic bone marrow transplantation, autologous bone marrowtransplantation, and aggressive chemotherapy in children with acute myeloid leukemia in remission. Blood, 2001; 97: 56-62.
148. Barnes, D. W. H., & Loutit, J. F. Treatment of murine leukemia with x-rays and homologous bone marrow: II. Br J Haematol, 1957; 3: 241-52.
149. Dausset, J. Iso-leuco-anticorps. Acta Haematol, 1958; 20: 156-66.
150. Thomas, E. D., Buckner, C. D., Rudolph, R. H., et al. Allogeneic marrow grafting for hematologic malignancy using HL-A-matched donor recipient sibling pairs. Blood, 1971; 38: 267-87.
151. Pinkel, D. Bone marrow transplantation in children. J Pediatr, 1993; 122: 331-41.
152. Fefer, A., Cheever, M. A., Thomas, E. D., et al. Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin. N Engl J Med, 1979; 300: 333-7.
153. Galton, D. A. G. Myleran in chronic myeloid leukemia. Results of treatment. Lancet, 1953; 264: 208-13.
154. Fishbein, W. N., Carbone, P. P., Freireich, E. J., et al. Clinical trials of hydroxyurea in patients with cancer and leukemia. Clin Pharmacol Ther, 1965; 5: 574-80.
155. Sanders, J., Buckner, C., Thomas, E. D., et al. Allogeneic marrow transplantation for children with juvenile chronic myelogenous leukemia. Blood, 1988; 71: 1144-6.
156. Bunin, N., Casper, J., Chitambar, C., et al. Partially matched bonemarrowtransplantation in patients withmyelodysplastic syndromes. J Clin Oncol, 1988; 6: 1851-5.
157. Appelbaum, F. R., Clift, R. A., Buckner, C. D., et al. Allogeneic marrowtransplantation for acute nonlymphoblastic leukemia after first relapse. Blood, 1983; 61: 949-53.
158. Dopfer, R., Henze, G., Bender-Gotze, C., et al. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission after intensive primary and relapse therapy according to the BFM and Co-ALL protocols; results of the German cooperative study. Blood, 1991; 78: 2780-4.
159. Harrison, G., Richards, S., Lawson, S., et al. Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. Ann Oncol, 2000; 11: 999-1006.
160. Gaynon, P. S., Harris, R. E., Trigg, M. E., et al. Chemotherapy (CT) vs. BMT for children (pts) with acute lymphoblastic leukemia (ALL) and early marrow relapse (MR): CCG-1941. Blood, 2000; 96: 418a.
161. Pui, C. H., Gaynon, P. S., Boyett, J. M., et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomalregion. Lancet, 2002; 359: 1909-15.
162. Pinkel, D. Treatment of children with acute myeloid leukemia. Blood, 2001; 97: 3673.
163. Giralt, S., Estey, E., Albitar, M., et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versusleukemia without myeloablative therapy. Blood, 1997; 89: 4531-6.
164. Talpaz, M., Kantarjian, H. M., & McCredie, K. Hematologic remission and cytogenetic improvement induced by human interferon alpha in chronic myelogenous leukemia. N Engl J Med, 1986; 314: 1065-9.
165. Talpaz, M., Kantarjian, H., Kurzrock, R., et al. Interferon-alpha produces sustained cytogenetic responses in chronic myelogenous leukemia. Ann Intern Med, 1991; 114: 532-8.
166. Dow, L., Raimondi, S., Culbert, S., et al. Response to alpha-interferon in children with Philadelphia chromosomepositive chronic myelocytic leukemia. Cancer, 1991; 68: 1678-84.
167. Pinkel, D. & Granoff, A., eds. Genetic Targeting in Leukemia. Accomplishments in Oncology, vol. 2 (no. 2) (Philadelphia, PA: J. B. Lippincott, 1988).
168. Huang, M. E., Ye, Y. C., Chen, S. R., et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 1988; 72: 567-72.
169. De Thé, H., Lavau, C., Marchio, A., et al. The PML-RAR fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR_. Cell, 1991; 66: 675-84.
170. Fenaux, P., Wattel, E., Archimbaud, E., et al. Prolonged followupconfirmsthat all-transretinoic acid followedbychemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. Blood, 1994; 84: 666-7.
171. Druker, B. J. & Lydon, N. B. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia. J Clin Invest, 2000; 105: 3-7.
172. Mauro, M. J., O'Dwyer, M., Heinrich, M. C., Druker, B. J. STI 571: a paradigm of new agents for cancer therapeutics. J Clin Oncol, 2001; 20: 325-334.
173. Yeoh, E. J., Ross, M. E., Shurtleff, S. A., et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell, 2002; 1: 133-43.
174. Chandy, M. Childhood acute lymphoblastic leukemia in India: an approach to management in a three-tier society. Med Pediatr Oncol, 1995; 25: 197-203.
175. Kun, L. E., Camitta, B. M., Mulhern, R. K., et al. Treatment of meningeal relapse in childhood acute lymphoblastic leukemia. I. Results of craniospinal irradiation. J Clin Oncol, 1984; 2: 359-64.
176. Stoffel, T. J., Nesbit, M. E., Levitt, S. H. Extramedullary involvement of the testes in childhood leukemia. Cancer, 1975; 35: 1203-11.
177. Blundell, J. Successful case of transfusion. Lancet, 1828; 1: 431-2.
178. Landsteiner, K. Ueberagglutinationserscheinungennormalen menschlichen blutes. Wien Klin Wochenschr, 1901; 14: 1132-4.
179. Rous, P. & Turner, J. R. The preservation of living red blood cells in vitro I. Method of preservation. J Exp Med, 1916; 23: 219-37.
180. Robertson, O. H. Transfusion with preserved red blood cells. Br Med J, 1918; 1: 691-5.
181. Rous, P. & Robertson, O. H. The normal fate of erythrocytes I. The findings in healthy animals. J Exp Med, 1917; 25: 651-64.
182. Fantus, B. The therapy of the Cook County Hospital: blood preservation. JAMA, 1937; 109: 128-131.
183. Gardner, F. H., Howell, D. H., &Hirsch, E.O. Platelet transfusion utilizing plastic equipment. J Lab Clin Med, 1954; 43: 196-207.
184. McGovern, J. J. Platelet transfusions in pediatrics. New Engl J Med, 1957; 256: 922-7.
185. Rundles, R.W., Wyngarden, J. B., Hitchings, G. H., et al. Effects of the xanthine oxidase inhibitor, allopurinol, on thiopurine metabolism, hyperuricemia and gout. Trans Assoc Am Phy, 1963; 76: 126-40.
186. Pui, C.-H., Mahmond, H. H., Wiley, J. M., et al. Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol, 2001; 19: 697-704.
187. Pinkel, D. Chickenpox and leukemia. J Pediatr, 1961; 58: 729-37.
188. Feldman, S., Hughes, W. T., &Daniel, C. B. Varicella in children with cancer. Seventy-seven cases. Pediatrics, 1975; 56: 388-97.
189. Zaia, J. A., Levin, M. J., & Preblud, S. R., et al. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella. J Infect Dis, 1983; 147: 737-43.
190. Biron, K. K. & Elion, G. B. In vitro susceptibility of varicellazoster virus to acyclovir. Antimicrob Agents Chemother, 1980; 18: 443-7.
191. Prober, C. G., Kirk, L. E., & Keeney, R. E. Acyclovir therapy of chickenpox in immunosuppressed children: a collaborative study. J Pediatr, 1982; 101: 622-5.
192. Johnson, H.D.&Johnson, W.W. Pneumocystis cariniipneumonia in children with cancer. Diagnosis and treatment. JAMA, 1970; 214: 1067-73.
193. Perera, D. R., Western, K. A., Johnson, H.D., et al. Pneumocystis carinii pneumonia in a hospital for children. Epidemiologic aspects. JAMA, 1970; 214: 1074-8.
194. Ivady, G. & Paldy, L. A new method of treating interstitial plasma cell pneumonia in premature infants with pentavalent antimony and aromatic diamidines. Mschr Kinderheilk, 1958; 106: 10-14.
195. Hughes, W.T., Kuhn, S., Chaudhary, S., et al. Successfulchemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med, 1977; 297: 1419-26.
196. Frei, E., Levin, R. H., Bodey, G. P., et al. The nature and control of infections in patients with acute leukemia. Cancer Res, 1965; 25: 1511-15.
197. Bodey, G. P., Buckley, M., Sathe, Y. S., et al. Quantitative relationships between circulating leucocytes and infection in patients with acute leukemia. Ann Intern Med, 1966; 64: 328-40.
198. Pizzo, P. A., Ladisch, S., Simon, R. M., et al. Increasing incidence of gram-positive sepsis in cancer patients. Med Pediatr Oncol, 1978; 5: 241-4.
199. Young, R. C., Bennett, J. E., Geelhoed, G. W., et al. Fungemia with compromised host resistance. Ann Intern Med, 1974; 80: 605-12.
200. Procknow, J. J. & Loosli, C. G. Treatment of the deep mycoses. AMA Arch Intern Med, 1958; 101: 765-802.
201. Galgiani, J. N. Fluconazole, a new antifungal agent. Ann Intern Med, 1990; 113: 177-9.
202. Vernick, V. & Karon, M. Who's afraid of death on a leukemia ward? Am J Dis Child, 1965; 109: 393-7.
203. Soni, S. S., Marten, G. W., Pitner, S. E., et al. Effects of central nervous system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia. N Engl J Med, 1975; 293: 113-18.
204. Pinkel, D. Selecting treatment for children with acute lymphoblastic leukemia. J Clin Oncol, 1996; 14: 4-6.
205. Mathé, G., Amiel, J. L., Schwarzenberg, L., et al. Active immunotherapy for acute lymphoblastic leukemia. Lancet, 1969; 1: 697-9.
206. Kay, H. Treatment of acute lymphoblastic leukemia.Comparison of immunotherapy (BCG), intermittent methotrexate, and no therapy after a 5 month intensive cytotoxic regimen (Concord trial). Br Med J, 1971; 4: 189-94.
207. Heyn, R. M., Joo, P., Karon, M., et al. BCG in the treatment of acute lymphocytic leukemia. Blood, 1975; 46: 431-42.